By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug Administration granted accelerated approval for tovorafenib (Ojemda, Day One Biopharmaceuticals, Inc.) for relapsed or refractory pediatric low-grade
Dr. Luke Fletcher Willamette Valley Cancer Institute & Research Center Philadelphia positive acute lymphoblastic leukemia treatment has been driven by the combination of tyrosine kinase inhibitors targeting BCR-ABL in conjunction with
MoreDr. Aditi Sharma of Barbara Ann Karmanos Cancer Institute & Dr. Abhishek Mangaonkar of Mayo Clinic In the phase III AGILE trial reported in the New England Journal of Medicine, Pau
MoreBy Luke Fletcher, MD Willamette Valley Cancer Institute & Research Center Imetelstat, a telomerase inhibitor, has shown interesting promise for ESA refractory or unlikely to respond low-risk Myelodysplastic syndrome (MDS). In
MoreBy Paolo Tarantino, MD Dana-Farber Cancer Institute/Harvard Medical School “Overall, a major shift in the way we treat breast cancer has occurred in 2022, with the demonstration that patients with tumors
MoreOncologists Interested in Improving Access to Cancer Care Encouraged to Apply Are you an oncologist who is passionate about educating fellow providers? We invite you to apply to join the Binaytara Foundation
MoreASH Review Portland, Highlights from SABCS, and Thoracic Oncology San Diego The Binaytara Foundation is facilitating three conferences with varying focuses at the beginning of the year. These meetings include BTF’s ASH
MoreMeet Chris Nevala-Plagemann, MD, Katie Kerrigan, DO, and Theresa Werner, MD! In this week’s faculty highlight, we present Drs. Chris Nevala-Plagemann, Katie Kerrigan, and Theresa Werner. These three doctors joined us as
MoreSenior Fellows and Early Career Oncologists Interested in Cancer Health Disparities are Encouraged to Apply Interested in being mentored by oncologists and writing conference summaries for publication in a peer-reviewed journal? Apply
MoreSubmit Your Research for Presentation at Our Cancer Disparities Summit The Binaytara Foundation invites you to submit your research for our Summit on Cancer Health Disparities (SCHD23) in Seattle, WA, on April
MoreFrary shares about volunteering with the Binaytara Foundation and her passion for serving the community Meet Grace Frary, one of the volunteers at the Binaytara Foundation! Frary recently supported our October Thoracic
More